HDV Can Constrain HBV Genetic Evolution in HBsAg: Implications for the Identification of Innovative Pharmacological Targets

Chronic HBV + HDV infection is associated with greater risk of liver fibrosis, earlier hepatic decompensation, and liver cirrhosis hepatocellular carcinoma compared to HBV mono-infection. However, to-date no direct anti-HDV drugs are available in clinical practice. Here, we identified conserved and...

Descripción completa

Detalles Bibliográficos
Autores principales: Colagrossi, Luna, Salpini, Romina, Scutari, Rossana, Carioti, Luca, Battisti, Arianna, Piermatteo, Lorenzo, Bertoli, Ada, Fabeni, Lavinia, Minichini, Carmine, Trimoulet, Pascale, Fleury, Hervé, Nebuloso, Elena, De Cristofaro, Maria, Cappiello, Giuseppina, Spanò, Alberto, Malagnino, Vincenzo, Mari, Terenzio, Barlattani, Angelo, Iapadre, Nerio, Lichtner, Miriam, Mastroianni, Claudio, Lenci, Ilaria, Pasquazzi, Caterina, De Sanctis, Giuseppe Maria, Galeota Lanza, Alfonso, Stanzione, Maria, Stornaiuolo, Gianfranca, Marignani, Massimo, Sarmati, Loredana, Andreoni, Massimo, Angelico, Mario, Ceccherini-Silberstein, Francesca, Perno, Carlo-Federico, Coppola, Nicola, Svicher, Valentina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6071122/
https://www.ncbi.nlm.nih.gov/pubmed/29987240
http://dx.doi.org/10.3390/v10070363

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6071122/
https://www.ncbi.nlm.nih.gov/pubmed/29987240
http://dx.doi.org/10.3390/v10070363

Ejemplares similares